Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,329–2,336 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Johnson & Johnson Icotrokinra (JNJ-2113) - (ANTHEM-UC) Ulcerative colitis Phase 2b Data Released Oral Gastroenterology
Johnson & Johnson Seltorexant - (MIN-202) Primary insomnia Phase 2b Trial Completed Oral Psychiatric
Johnson & Johnson HVTN 705/HPX2008 (Imbokodo) HIV in Women Phase 2b Intramuscular Anti-HIV
Johnson & Johnson PN-235 (JNJ-77242113) - (FRONTIER 1) Plaque psoriasis Phase 2b Data Released Oral Immunology: Anti-TNF
Johnson & Johnson TALVEY (talquetamab-tgvs) and TECVAYLI (teclistamab-cqyv) - (RedirecTT-1 ) Multiple Myeloma Phase 2 Data Released Subcutaneous Oncology
Johnson & Johnson JNJ-4804 - (AFFINITY) Psoriatic Arthritis Phase 2 Ongoing oral Immunology: Anti-TNF
Johnson & Johnson Nipocalimab - (DAHLIAS) Sjögren's disease (SjD) Phase 2 Data Released Intravenous Immunology
Johnson & Johnson NM26 Atopic dermatitis (AD) Phase 2 Trial Planned Intravenous Immunology